GPX4 and hepatocellular carcinoma: A study found that the release of miR-6805 from its target genes, apoptosis-inducing factor mitochondria-associated 2 (AIFM2) and GPX4, inhibited ferroptosis and promoted tumor development in hepatocellular carcinoma (HCC) [128].